Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 13, 1999, Pages 7462-7466

  Nussenblatt, Robert B ^a   Fortin, Eric ^a   Schiffman, Rhett ^a   Rizzo, Luiz ^a   Smith, Janine ^a   Van Veldhuisen, Paul ^a   Sran, Pushpa ^b,c   Yaffe, Anita ^a   Goldman, Carolyn K ^d   Waldmann, Thomas A ^d   Whitcup, Scott M ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; PREDNISONE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; UVEITIS;

ADULT; ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDNISONE; TH1 CELLS; TREATMENT OUTCOME; UVEITIS;

EID: 13044311376     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.13.7462     Document Type: Article

References (14)

1. Nussenblatt, R. B. (1991) Invest. Ophthalmol. Vis. Sci. 32, 3131-3141.
2. Caspi, R. R. & Nussenblatt, R. B. (1994) in Autoimmunity: Physiology and Disease, eds. Coutinho, A. & Kazatchkine, M. (Wiley-Liss, New York), pp. 377-404.
3. Caspi, R. R., Roberge, F. G., McAlliser, C. G., el-Saied, M., Kuwabara, T., Gery, I., Hanna, E. & Nussenblatt, R. B. (1986) J. Immunol. 136, 928-933.
4. Feron, E. J., Calder, V. L. & Lightman, S. L. (1992) Curr. Eye Res. 11 Suppl., 167-172.
5. Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., et al. (1998) N. Engl. J. Med. 338,161-165.
6. Guex-Crosier, Y., Raber, J., Chan, C. C., Kriete, M. S., Benichou, J., Pilson, R. S., Kerwin, J. A., Waldmann, T. A., Hakimi, J. & Roberge, F. G. (1997) J. Immunol. 158, 452-458.
7. Nussenblatt, R. B., Palestine, A. G., Chan, C. C. & Roberge, F. (1985) Ophthalmology 92, 467-471.
8. Hogan, M. J., Kimura, S. J. & Thygensen, P. (1959) Am. J. Ophthalmol. 47, 155-170.
9. Ferris, F. L., III, Kassoff, A., Bresnick, G. H. & Bailey, I. (1982) Am. J. Ophthalmol. 94, 91-96
10. Hakimi, J., Seals, C., Anderson, L. E., Podlaski, F. J., Lin, P., Danho, W., Jenson, J. C., Perkins, A., Donadio, P. E., Familletti, P. C., et al. (1987) J. Biol. Chem. 262, 17336-17341.
11. Liang, K. Y. & Zeger, S. L. (1986) Biometrika 73,13-22.
12. Zeger, S. L. & Liang, K. Y. (1986) Biometrics 42,121-130.
13. Depper, J. M., Leonard, W. J., Robb, R. J., Waldmann, T. A. & Green, W. C. (1983) J. Immunol. 131, 690-696.
14. Yockey, S. M. & Ahmed, I. (1997) Mayo Clin. Proc. 72, 1151-1152.